Sandner et al., 2006 - Google Patents
First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachmentSandner et al., 2006
- Document ID
- 6434995545233003942
- Author
- Sandner D
- Engelmann K
- Publication year
- Publication venue
- Graefe's Archive for Clinical and Experimental Ophthalmology
External Links
Snippet
Background In this study, we evaluated the anatomic and functional outcome and intraocular adverse effects after a 3-month endotamponade with Densiron 68, a mixture of F 6 H 8 with silicone oil, in complex inferior re-detachments. Methods Forty-eight eyes of 48 patients …
- 229920002545 silicone oil 0 title abstract description 44
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/912—Ophthalmic
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sandner et al. | First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment | |
| Sandner et al. | High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up | |
| Theelen et al. | Intraocular inflammation following endotamponade with high-density silicone oil | |
| Jonas et al. | Intraocular pressure and silicone oil endotamponade | |
| Hengerer et al. | Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results | |
| Al-Jazzaf et al. | Incidence and management of elevated intraocular pressure after silicone oil injection | |
| Guedes et al. | One-year comparative evaluation of iStent or iStent inject implantation combined with cataract surgery in a single center | |
| Enaida et al. | Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases | |
| Garcia-Valenzuela et al. | Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery | |
| Duan et al. | Complications after heavy silicone oil tamponade in complicated retinal detachment | |
| Sonoda et al. | Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study | |
| Rush et al. | Postoperative perfluoro-N-octane tamponade for primary retinal detachment repair | |
| Zhuo et al. | Phacoemulsification treatment of subjects with acute primary angle closure and chronic primary angle-closure glaucoma | |
| Buffault et al. | Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma | |
| Avar et al. | Long-term follow-up of intraocular pressure and pressure-lowering medication in patients after ab-interno trabeculectomy with the Trabectome | |
| Schargus et al. | Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma | |
| Wong et al. | Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case–control study | |
| Levasseur et al. | High-density silicone oil Densiron-68 as an intraocular tamponade for primary inferior retinal detachments | |
| Lin et al. | Incidence of endophthalmitis after 23-gauge pars plana vitrectomy | |
| Wilkie et al. | Equine glaucoma | |
| Rojas-Juárez et al. | Autologous full-thickness retinal transplant for refractory large macular holes | |
| Kiuchi et al. | Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma | |
| Holzer et al. | Corneal flap complications in refractive surgery: part 2: postoperative treatments of diffuse lamellar keratitis in an experimental animal model | |
| Stolba et al. | The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution | |
| Yülek et al. | Effect of topical steroids on corneal epithelial healing after vitreoretinal surgery |